Sugi Predict

Sugi Predict / Compounds / SCHEMBL4590083

SCHEMBL4590083

SCHEMBL4590083

CC(C)(C)OC(=O)N1CCc2ccc(C#C[Si](C)(C)C)cc2C1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.62
▸ ESR2 Q92731 2/20 0.57
▸ ABHD6 Q9BV23 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ IGF1R P08069 1/20 0.42
▸ GABRA1 P14867 2/20 0.41
▸ GABRG2 P18507 2/20 0.41
▸ GABRB3 P28472 2/20 0.41
▸ GABRA5 P31644 2/20 0.41
▸ GABRA3 P34903 2/20 0.41
▸ GABRA2 P47869 2/20 0.41
▸ GABRA6 Q16445 2/20 0.41
▸ UCHL1 P09936 1/20 0.41
▸ GABRB2 P47870 1/20 0.41
▸ GABRA4 P48169 1/20 0.41
▸ GRM5 P41594 2/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ DDB1 Q16531 1/20 0.41
▸ CRBN Q96SW2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3011371 0.95 ESR2 (0.63) NR1H2ESR2ABHD6MAPK1GABRA1
SCHEMBL24676283 0.84 NR1H2 (0.62) NR1H2ESR2ABHD6MAPK1IGF1R
SCHEMBL30409049 0.83 NR1H2 (0.67) NR1H2ESR2ABHD6MAPK1IGF1R
SCHEMBL2416879 0.83 NR1H2 (0.67) NR1H2ESR2MAPK1HDAC1MAPT
SCHEMBL5127638 0.83 NR1H2 (0.67) NR1H2ESR2ABHD6MAPK1IGF1R
SCHEMBL29586616 0.83 NR1H2 (0.67) NR1H2ESR2MAPK1HDAC1MAPT
SCHEMBL3009981 0.82 MAPT (0.48) NR1H2ESR2MAPK1GABRA1GABRG2
SCHEMBL21747817 0.81 CHRM4 (0.48) NR1H2ESR2GABRA1GABRG2GABRB3
SCHEMBL30409090 0.79 ESR2 (0.69) NR1H2ESR2ABHD6MAPK1GABRA1
SCHEMBL3009208 0.79 ESR2 (0.69) NR1H2ESR2ABHD6MAPK1GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459321-B2 Broad spectrum antiviral compositions and methods EVRYS BIO, LLC (US) 2022-10-04 — — US disclosed
US-20210139475-A1 Broad Spectrum Antiviral Compositions and Methods EVRYS BIO, LLC (US) 2021-05-13 — — US disclosed
WO-2019079519-A1 BROAD SPECTRUM ANTIVIRAL COMPOSITIONS AND METHODS FORGE LIFE SCIENCE, LLC (US) 2019-04-25 — — WO disclosed
US-20080200454-A1 CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. 2008-08-21 — — US disclosed
WO-2008100618-A2 CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S SUNESIS PHARMACEUTICALS, INC. (US) 2008-08-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11459321-B2 Broad spectrum antiviral compositions and methods IRF3, MAVS, ZC3HAV1 NR1H2 1472/4885ESR2 3487/4885ABHD6 3794/4885
US-20080200454-A1 CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S CTSS, CTSK, CTSZ NR1H2 728/4885ESR2 1521/4885ABHD6 4763/4885
US-20210139475-A1 Broad Spectrum Antiviral Compositions and Methods MAVS, IRF3, ZC3HAV1 NR1H2 1583/4885ESR2 3095/4885ABHD6 2978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.